EdgeMarket › What Farallon Capital Management Llc reported owning
What Farallon Capital Management Llc reported owning
As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.
Reported value
17.5BPositions
172Quarter
2026-03-31Shown below
50largest by value
| holding | value | % of book | shares | price | 1y |
|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. | 1.3B | 7.5% | 13.6M | 209.46 | +479.3% |
| AMZN AMAZON COM INC | 878.6M | 5.0% | 4.2M | 258.63 | +15.6% |
| MSFT MICROSOFT CORP | 868.0M | 4.9% | 2.3M | 483.24 | -4.4% |
| AON Aon plc | 811.0M | 4.6% | 2.5M | 355.11 | -5.1% |
| BBIO BridgeBio Pharma, Inc. | 695.5M | 4.0% | 9.4M | 81.50 | +66.7% |
| PTGX Protagonist Therapeutics, Inc | 669.2M | 3.8% | 6.3M | 154.32 | +174.4% |
| NTRA Natera, Inc. | 641.4M | 3.7% | 3.2M | 332.03 | +106.7% |
| EXEL EXELIXIS, INC. | 562.3M | 3.2% | 13.1M | 54.08 | +42.8% |
| AVGO Broadcom Inc. | 550.8M | 3.1% | 1.8M | 368.45 | +26.5% |
| UNH UNITEDHEALTH GROUP INC | 492.9M | 2.8% | 1.8M | 390.11 | +30.1% |
| SNPS SYNOPSYS INC | 481.0M | 2.7% | 1.2M | 397.87 | -33.8% |
| BSX BOSTON SCIENTIFIC CORP | 468.8M | 2.7% | 7.5M | 50.37 | -52.5% |
| TMO THERMO FISHER SCIENTIFIC INC. | 433.3M | 2.5% | 881.5K | 629.27 | +27.2% |
| KKR KKR & Co. Inc. | 432.1M | 2.5% | 4.7M | 108.48 | -21.4% |
| LNTH Lantheus Holdings, Inc. | 423.5M | 2.4% | 5.6M | 99.97 | +78.1% |
| WAB WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP | 402.2M | 2.3% | 1.6M | 297.57 | +54.3% |
| SCHW SCHWAB CHARLES CORP | 371.8M | 2.1% | 4.0M | 112.30 | +17.6% |
| LQDA Liquidia Corp | 326.7M | 1.9% | 8.7M | 68.62 | +150.9% |
| CRNX Crinetics Pharmaceuticals, Inc. | 302.8M | 1.7% | 8.3M | 84.69 | +191.1% |
| GOOG Alphabet Inc. | 285.8M | 1.6% | 996.2K | 341.75 | +70.7% |
| ROIV Roivant Sciences Ltd. | 268.0M | 1.5% | 9.7M | 36.30 | +209.7% |
| V VISA INC. | 254.1M | 1.4% | 840.7K | 371.04 | +7.9% |
| ARMK Aramark | 248.7M | 1.4% | 6.1M | 59.77 | +49.2% |
| BEAM Beam Therapeutics Inc. | 241.5M | 1.4% | 10.1M | 29.76 | +85.3% |
| DIS Walt Disney Co | 231.5M | 1.3% | 2.4M | 107.78 | -7.9% |
| MA Mastercard Inc | 217.4M | 1.2% | 435.1K | 580.63 | -2.0% |
| MCK MCKESSON CORP | 202.8M | 1.2% | 234.3K | 858.90 | +22.2% |
| AGIO AGIOS PHARMACEUTICALS, INC. | 192.3M | 1.1% | 5.7M | 33.09 | -10.1% |
| unmapped CUSIP 152309100 | 191.0M | 1.1% | 4.8M | — | — |
| TNGX Tango Therapeutics, Inc. | 190.3M | 1.1% | 9.1M | 23.88 | +253.8% |
| GRAL GRAIL, Inc. | 168.2M | 1.0% | 3.3M | 79.54 | +147.2% |
| TYRA Tyra Biosciences, Inc. | 137.1M | 0.8% | 3.6M | 26.05 | +154.4% |
| THC TENET HEALTHCARE CORP | 85.3M | 0.5% | 452.2K | 280.77 | +54.3% |
| CAH CARDINAL HEALTH INC | 77.8M | 0.4% | 368.0K | 229.51 | +50.1% |
| PCVX Vaxcyte, Inc. | 73.3M | 0.4% | 1.3M | 62.62 | +100.3% |
| DNTH Dianthus Therapeutics, Inc. /DE/ | 70.2M | 0.4% | 836.0K | 111.10 | +374.4% |
| BTSG BrightSpring Health Services, Inc. | 68.9M | 0.4% | 1.6M | 58.87 | +149.1% |
| TWST Twist Bioscience Corp | 67.8M | 0.4% | 1.4M | 145.59 | +450.4% |
| BIDU Baidu, Inc. | 49.4M | 0.3% | 443.8K | 93.21 | +7.4% |
| CGON CG Oncology, Inc. | 45.6M | 0.3% | 674.0K | 79.81 | +212.6% |
| AZN ASTRAZENECA PLC | 44.7M | 0.3% | 226.5K | 165.98 | — |
| unmapped CUSIP 90138AAE3 | 44.5M | 0.3% | 45.0M | — | — |
| MRK Merck & Co., Inc. | 43.4M | 0.2% | 361.0K | 152.55 | +80.2% |
| ACHC Acadia Healthcare Company, Inc. | 40.6M | 0.2% | 1.7M | 27.82 | +30.6% |
| WELL WELLTOWER INC. | 39.5M | 0.2% | 200.0K | 239.22 | +44.1% |
| IMVT Immunovant, Inc. | 38.4M | 0.2% | 1.5M | 44.37 | +199.4% |
| ENTA ENANTA PHARMACEUTICALS INC | 36.3M | 0.2% | 2.9M | 13.47 | +52.7% |
| JNJ JOHNSON & JOHNSON | 36.2M | 0.2% | 148.0K | 270.24 | +51.1% |
| BBNX Beta Bionics, Inc. | 36.2M | 0.2% | 3.6M | 19.05 | +24.5% |
| ASMB ASSEMBLY BIOSCIENCES, INC. | 34.1M | 0.2% | 1.2M | 34.38 | +31.5% |
A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →
The whole archive is one click away.
Screener, filings, insider flow, backtests and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →